Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Lung Disease, Induced by Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Carcinoma.
Saved in:
| Title: | Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Lung Disease, Induced by Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Carcinoma. |
|---|---|
| Authors: | Saito A; Department of Urology Saiseikai Kawaguchi General Hospital Saitama Japan.; Department of Urology Tokyo Women's Medical University Tokyo Japan., Ishihara H; Department of Urology Saiseikai Kawaguchi General Hospital Saitama Japan.; Department of Urology Tokyo Women's Medical University Tokyo Japan., Kondo H; Department of Urology Tokyo Women's Medical University Tokyo Japan., Takagi T; Department of Urology Tokyo Women's Medical University Tokyo Japan., Hashimoto Y; Department of Urology Saiseikai Kawaguchi General Hospital Saitama Japan. |
| Source: | IJU case reports [IJU Case Rep] 2026 Feb 05; Vol. 9 (2), pp. e70148. Date of Electronic Publication: 2026 Feb 05 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Australia, Ltd Country of Publication: Australia NLM ID: 101764958 Publication Model: eCollection Cited Medium: Internet ISSN: 2577-171X (Electronic) Linking ISSN: 2577171X NLM ISO Abbreviation: IJU Case Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2577-171X |
|---|---|
| DOI: | 10.1002/iju5.70148 |
